Lenvatinib
DrugBank ID: DB09078
Summary
| Metric | Value |
|---|---|
| Total Predictions | 53 |
| KG+DL (Dual Validated) | 4 |
| DL Only | 46 |
| KG Only | 3 |
Predictions
| Indication | Score | Source |
|---|---|---|
| clear cell renal carcinoma | 0.9957 | KG+DL |
| liposarcoma | 0.9951 | DL |
| renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions | 0.9949 | DL |
| renal cell carcinoma associated with neuroblastoma | 0.9949 | DL |
| unclassified renal cell carcinoma | 0.9949 | DL |
| ovarian myxoid liposarcoma | 0.9947 | DL |
| childhood kidney cell carcinoma | 0.9938 | DL |
| renal carcinoma | 0.9937 | DL |
| angiolipoma | 0.9935 | DL |
| renal cell carcinoma (disease) | 0.9932 | KG+DL |
| familial spontaneous pneumothorax | 0.9929 | DL |
| endocrine-cerebro-osteodysplasia syndrome | 0.9921 | DL |
| collecting duct carcinoma | 0.9921 | DL |
| renal pelvis carcinoma | 0.9912 | DL |
| nonpapillary renal cell carcinoma | 0.9910 | KG+DL |
| chromophobe renal cell carcinoma | 0.9902 | DL |
| sarcomatoid renal cell carcinoma | 0.9899 | DL |
| amyotrophic lateral sclerosis | 0.9881 | DL |
| bilateral parasagittal parieto-occipital polymicrogyria | 0.9879 | DL |
| Mills syndrome | 0.9869 | DL |
| amyotrophic lateral sclerosis, susceptibility to | 0.9868 | DL |
| amyotrohpic lateral sclerosis type 22 | 0.9868 | DL |
| acquired cystic disease-associated renal cell carcinoma | 0.9866 | DL |
| cystic renal cell carcinoma | 0.9866 | DL |
| kidney medullary carcinoma | 0.9866 | DL |
| axial spondylometaphyseal dysplasia | 0.9862 | DL |
| multilocular clear cell renal cell carcinoma | 0.9857 | DL |
| vulva sarcoma | 0.9853 | DL |
| glycogen storage disease due to lactate dehydrogenase H-subunit deficiency | 0.9852 | DL |
| spindle cell liposarcoma | 0.9845 | DL |
| renal pelvis adenocarcinoma | 0.9843 | DL |
| heart fibrosarcoma | 0.9840 | DL |
| trichomegaly-retina pigmentary degeneration-dwarfism syndrome | 0.9832 | DL |
| undifferentiated carcinoma of liver and intrahepatic biliary tract | 0.9831 | DL |
| fibroblastic neoplasm | 0.9830 | DL |
| X-linked hydrocephalus with stenosis of the aqueduct of Sylvius | 0.9830 | DL |
| kidney fibrosarcoma | 0.9828 | DL |
| paroxysmal dyskinesia | 0.9826 | DL |
| monomelic amyotrophy | 0.9825 | DL |
| autosomal dominant mitochondrial myopathy with exercise intolerance | 0.9824 | DL |
| X-linked complicated corpus callosum dysgenesis | 0.9823 | DL |
| Wolffian duct adenocarcinoma | 0.9823 | DL |
| conventional fibrosarcoma | 0.9821 | DL |
| renal cell adenocarcinoma | 0.9817 | KG+DL |
| low grade fibromyxoid sarcoma | 0.9812 | DL |
| lower motor neuron syndrome with late-adult onset | 0.9809 | DL |
| pyruvate dehydrogenase E1-beta deficiency | 0.9804 | DL |
| lethal arthrogryposis-anterior horn cell disease syndrome | 0.9799 | DL |
| adenocarcinoma of liver and intrahepatic biliary tract | 0.9786 | DL |
| bone fibrosarcoma | 0.9771 | DL |
Showing top 50 of 53 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.